Eric Dobmeier
Chairman
Jade Biosciences, Inc. (JBIO)Board Member
Jade Biosciences, Inc. (JBIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Dobmeier
Eric Dobmeier is recorded as Chairman and Board Member at Jade Biosciences, Inc. (JBIO). Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Eric Dobmeier was appointed Chair of the Board. Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Eric Dobmeier was appointed Chair of the Board, effective April 28, 2025. Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Eric Dobmeier was appointed Board of Directors, effective April 28, 2025.
“In connection with his appointment to the Board, Eric Dobmeier was also appointed as Chair of the Board.”
“In connection with his appointment to the Board, Eric Dobmeier was also appointed as Chair of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-04-28–present
-
Current
2025-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jade Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Tom Frohlich CEO, Board Member
- Bradford Dahms CFO
- Andrew King CTO
- Elizabeth Balta General Counsel
- Christopher Cain Board Member
- Continuing Directors Board Member
- Donald J. Santel Board Member
- Erin Lavelle Board Member
- Habib J. Dable Board Member
- Lawrence Klein Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.